Literature DB >> 15720996

Nonstandard pancreatic resections for unusual lesions.

Gerard V Aranha1, Margo Shoup.   

Abstract

BACKGROUND: Pancreatic resections including pancreaticoduodenectomy and distal pancreatectomy are the standard of care for patients with malignant tumors of the pancreas. Patients with benign disease or unusual tumors may benefit from other nonstandard resections.
METHODS: A review of the literature and the author's experiences were undertaken.
RESULTS: Parenchymal-sparing surgeries including pancreatic enucleation, central pancreatectomy, splenic-preserving distal pancreatectomy, and duodenal-preserving pancreatic head resection are described. The utility of each procedure is reviewed. Outcome results from published series are included.
CONCLUSIONS: Nonstandard pancreatic resections should be considered in select patients with unusual lesions. Such procedures are safe and effective and may be associated with a reduced incidence of exocrine insufficiency.

Entities:  

Mesh:

Year:  2005        PMID: 15720996     DOI: 10.1016/j.amjsurg.2004.11.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  18 in total

1.  Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases.

Authors:  Alessandro Zerbi; Vanessa Capitanio; Letizia Boninsegna; Claudio Pasquali; Guido Rindi; Gianfranco Delle Fave; Marco Del Chiaro; Riccardo Casadei; Massimo Falconi
Journal:  Langenbecks Arch Surg       Date:  2010-09-21       Impact factor: 3.445

2.  Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Authors:  Zhiwen Xiao; Guopei Luo; Zuqiang Liu; Kaizhou Jin; Jin Xu; Chen Liu; Liang Liu; Quanxing Ni; Jiang Long; Xianjun Yu
Journal:  HPB (Oxford)       Date:  2015-11-17       Impact factor: 3.647

3.  Laparoscopic versus open enucleation for pancreatic neoplasms: clinical outcomes and pancreatic function analysis.

Authors:  Ren-Chao Zhang; Yu-Cheng Zhou; Yi-Ping Mou; Chao-Jie Huang; Wei-Wei Jin; Jia-Fei Yan; Yong-Xiang Wang; Yi Liao
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

4.  Position of the Pancreas Division Line and Postoperative Outcomes After Distal Pancreatectomy.

Authors:  Satoshi Matsui; Toshiro Ogura; Daisuke Ban; Kosuke Ogawa; Hiroaki Ono; Yusuke Mitsunori; Atsushi Kudo; Shinji Tanaka; Minoru Tanabe
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

Review 5.  Management of mucinous cystic neoplasms of the pancreas.

Authors:  Mario Testini; Angela Gurrado; Germana Lissidini; Pietro Venezia; Luigi Greco; Giuseppe Piccinni
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

6.  Central pancreatectomy revisited.

Authors:  Kevin K Roggin; Udo Rudloff; Leslie H Blumgart; Murray F Brennan
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

7.  Robotic-assisted minimally invasive central pancreatectomy: technique and outcomes.

Authors:  Gerard J Abood; M Fatih Can; Mustapha Daouadi; Harold T Huss; Jennifer Y Steve; Lekshmi Ramalingam; Michael Stang; David L Bartlett; Herbert J Zeh; A James Moser
Journal:  J Gastrointest Surg       Date:  2013-01-17       Impact factor: 3.452

8.  Middle pancreatectomy: indications, short- and long-term operative outcomes.

Authors:  Stefano Crippa; Claudio Bassi; Andrew L Warshaw; Massimo Falconi; Stefano Partelli; Sarah P Thayer; Paolo Pederzoli; Carlos Fernández-del Castillo
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

9.  Middle segment pancreatectomy: a useful tool in the management of pancreatic neoplasms.

Authors:  Claudio Bassi
Journal:  J Gastrointest Surg       Date:  2007-06       Impact factor: 3.452

10.  Clinical efficacy of organ-preserving pancreatectomy for benign or low-grade malignant potential lesion.

Authors:  Seung Eun Lee; Jin-Young Jang; Dae Wook Hwang; Kuhn Uk Lee; Sun-Whe Kim
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.